Arcellx Inc
ACLX
Mkt cap
$6.73B
EV/Sales
298.5
P/E ratio
N/A
FY Revenue
$22.29M
EPS
$-4.07
Gross Margin
0.00%
Profit Margin
-1027.25%
Beta
N/A
Div yield
N/A
Sector
Healthcare
No recent filings in cache.
Arcellx Inc (ACLX) is a biotechnology company listed on NASDAQ.
Latest reported ACLX revenue for 2025-12-31 was $22.3M. Net income was -$228.9M. Revenue was down 79.4% from 2024-12-31 to 2025-12-31. ACLX currently screens at market cap $6.73B.
Use this ACLX page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the ACLX quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the ACLX SEC filings page. Lician reads the product cache first so this HTML stays unique to Arcellx Inc even when a live quote feed is slow.
Latest cached year on this hub. Full ACLX income, balance, and cash tables.
Arcellx Inc (ACLX) is a biotechnology company in the Healthcare sector.
Latest cached Arcellx Inc (ACLX) revenue for Dec 31, 2025 was $22.3M. Net income was -$228.9M. Statements: https://lician.com/financials/aclx
Arcellx Inc (ACLX) market capitalization is $6.73B on the latest cached snapshot.